NIH, Gates Foundation invest $200M to develop gene therapies for developing countries

The partnership will have a particular focus on therapies to treat sickle cell disease and HIV, with each party committing $100 million to the effort.

Continue reading on MedCity News

By MIT Sloan CDO
MIT Sloan CDO Profile Picture